Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes

References

• ScheinbergDAVillaCHEscorciaFEMcDevittMRConscripts of the infinite armada: systemic cancer therapy using nanomaterialsNat Rev Clin Oncol20107526627620351700
   PubMed Web of Science ®Google Scholar
• KostarelosKBiancoAPratoMPromises, facts and challenges for carbon nanotubes in imaging and therapeuticsNat Nanotechnol200941062763319809452
   PubMed Web of Science ®Google Scholar
• McDevittMRChattopadhyayDKappelBJTumor targeting with antibody-functionalized, radiolabeled carbon nanotubesJ Nucl Med20074871180118917607040
   PubMed Web of Science ®Google Scholar
• McDevittMRChattopadhyayDJaggiJSPET Imaging of soluble yttrium-86-labeled carbon nanotubes in micePLoS One200729e90717878942
   PubMed Web of Science ®Google Scholar
• VillaCHMcDevittMREscorciaFESynthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubesNano Lett20088124221422819367842
   PubMed Web of Science ®Google Scholar
• RuggieroAVillaCHBanderEParadoxical glomerular filtration of carbon nanotubesProc Natl Acad Sci U S A201010727123691237420566862
   PubMed Web of Science ®Google Scholar
• FoxMESzokaFCFrechetJMJSoluble polymer carriers for the treatment of cancer: the importance of molecular architectureAcc Chem Res20094281141115119555070
   PubMed Web of Science ®Google Scholar
• CoradaMLiaoFLindgrenMMonoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeabilityBlood20019761679168411238107
   PubMed Web of Science ®Google Scholar
• LiaoFDoodyJFOverholserJSelective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeabilityCancer Res20026292567257511980651
   PubMed Web of Science ®Google Scholar
• CoradaMZanettaLOrsenigoFA monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeabilityBlood2002100390591112130501
   PubMed Web of Science ®Google Scholar
• MayCDoodyJFAbdullahRIdentification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculatureBlood2005105114337434415701713
   PubMed Web of Science ®Google Scholar
• LamszusKBrockmannMAEckerichCInhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherinClin Cancer Res200511134934494016000592
   PubMed Web of Science ®Google Scholar
• McDevittMRMaDLaiLTTumor therapy with targeted atomic nano-generatorsScience200129455461537154011711678
   PubMed Web of Science ®Google Scholar
• BorchardtPEYuanRRMiedererMMcDevittMRScheinbergDATargeted actinium-225 in vivo generators for therapy of ovarian cancerCancer Res200363165084509012941838
   PubMed Web of Science ®Google Scholar
• MiedererMMcDevittMRSgourosGKramerKCheungNKScheinbergDAPharmacokinetics, dosimetry and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primatesJ Nucl Med200445112913714734685
   PubMed Web of Science ®Google Scholar
• BallangrudÅMYangWHPalmSAlpha-particle emitting atomic generator (actinium-225)-labeled trastuzumab (Herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expressionClin Cancer Res200410134489449715240541
   PubMed Web of Science ®Google Scholar
• MiedererMMcDevittMRBorchardtPTreatment of neuroblastoma meningeal carcinomatosis with intrathecal application of α-emitting atomic nanogenerators targeting disialo-ganglioside GD2Clin Cancer Res200410206985699215501978
   PubMed Web of Science ®Google Scholar
• YuanRRWongPMcDevittMRTargeted deletion of T-cell clones using alpha-emitting suicide MHC tetramersBlood20041082397240215217835
   PubMed Web of Science ®Google Scholar
• JurcicJGMcDevittMRDivgiCRAlpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225Cancer Biother Radiopharm20062214396
   Google Scholar
• RosenblatTLMcDevittMRPandit-TaskarNPhase I trial of the targeted alpha-particle nano-generator actinium-225 (225Ac)- HuM195 (Anti-CD33) in acute myeloid leukemia (AML)Blood200711011277A
   Web of Science ®Google Scholar
• MiedererMScheinbergDAMcDevittMRRealizing the potential of the actinium-225 radionuclide generator in targeted alphaparticle therapy applicationsAdv Drug Deliv Rev200860121371138218514364
   PubMed Web of Science ®Google Scholar
• McDevittMRSgourosGFinnRDRadioimmunotherapy with alpha-emitting radionuclidesEur J Nucl Med1998259134113519724387
   PubMedGoogle Scholar
• NikulaTNMcDevittMRFinnRDAlpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti- CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistryJ Nucl Med19994011661769935073
   PubMed Web of Science ®Google Scholar
• CalabreseCPoppletonHKocakMA perivascular niche for brain tumor stem cellsCancer Cell2007111698217222791
   PubMed Web of Science ®Google Scholar
• HambardzumyanDSquatritoMCarbajalEHollandECGlioma formation, cancer stem cells, and akt signalingStem Cell Rev20084320321018595010
   PubMed Web of Science ®Google Scholar
• HambardzumyanDBecherOJRosenblumMKPandolfiPPManova-TodorovaKHollandECPI3 K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivoGenes Dev200822443644818281460
   PubMed Web of Science ®Google Scholar
• JaggiJSHenkeESeshanSVSelective alpha-particle mediated depletion of tumor vasculature with vascular normalizationPLoS One200723e26717342201
   PubMed Web of Science ®Google Scholar
• NolanDJCiarrocchiAMellickASBone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularizationGenes Dev200721121546155817575055
   PubMed Web of Science ®Google Scholar
• VerelIVisserGWBoellaardRStigter-van WalsumMSnowGBvan DongenGA89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodiesJ Nucl Med20034481271128112902418
   PubMed Web of Science ®Google Scholar
• HollandJPShehYLewisJSStandardized methods for the production of high specific-activity zirconium-89Nucl Med Biol200936772973919720285
   PubMed Web of Science ®Google Scholar
• HollandJPWilliamsonMJLewisJSUnconventional nuclides for radiopharmaceuticalsMol Imaging20109112020128994
   PubMed Web of Science ®Google Scholar
• HollandJPCaldas-LopesEDivilovVMeasuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumabPLoS One201051e885920111600
   PubMed Web of Science ®Google Scholar
• RuggieroAHollandJPLewisJSGrimmJCerenkov luminescence imaging of medical isotopesJ Nucl Med20105171123113020554722
   PubMed Web of Science ®Google Scholar
• HollandJPDivilovVBanderNHSmith-JonesPMLarsonSMLewisJS89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivoJ Nucl Med20105181293130020660376
   PubMed Web of Science ®Google Scholar
• von SchulthessGKSteinertHCHanyTFIntegrated PET/CT: current applications and future directionsRadiology2006238240542216436809
   PubMed Web of Science ®Google Scholar
• GeorgakilasVTagmatarchisNPantarottoDBiancoABriandJPPratoMAmino acid functionalization of water soluble carbon nanotubesChem Commun (Camb)2002243050305112536811
   PubMed Web of Science ®Google Scholar
• TasisDTagmatarchisNBiancoAPratoMChemistry of carbon nanotubesChem Rev200610631105113616522018
   PubMed Web of Science ®Google Scholar
• SinghPCampidelliSGiordaniSBonifaziDBiancoAPratoMOrganic functionalisation and characterisation of single-walled carbon nanotubesChem Soc Rev20093882214223019623345
   PubMed Web of Science ®Google Scholar
• SinghRPantarottoDLacerdaLTissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracersProc Natl Acad Sci U S A200610393357336216492781
   PubMed Web of Science ®Google Scholar
• AllenBLKichambarePDGouPBiodegradation of single-walled carbon nanotubes through enzymatic catalysisNano Lett20088113899390318954125
   PubMed Web of Science ®Google Scholar
• AllenBLKotcheyGPChenYMechanistic investigations of horseradish peroxidase-catalyzed degradation of single- walled carbon nanotubesJ Am Chem Soc200913147171941720519891488
   PubMed Web of Science ®Google Scholar
• KonduruNVTyurinaYYFengWPhosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivoPLoS One200942e439819198650
   PubMed Web of Science ®Google Scholar
• KaganVEKonduruNVFengWCarbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammationNat Nanotechnol20105535435920364135
   PubMed Web of Science ®Google Scholar
• DumortierHLacotteSPastorinGFunctionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cellsNano Lett2006671522152816834443
   PubMed Web of Science ®Google Scholar
• SayesCMLiangFHudsonJLFunctionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitroToxicol Lett2006161213514216229976
   PubMed Web of Science ®Google Scholar
• SchipperMLNakayama-RatchfordNDavisCRA pilot toxicology study of single-walled carbon nanotubes in a small sample of miceNat Nanotechnol20083421622118654506
   PubMed Web of Science ®Google Scholar
• KostarelosKThe long and short of carbon nanotube toxicityNat Biotechnol200826777477618612299
   PubMed Web of Science ®Google Scholar
• McDevittMRMaDSimonJFrankRKScheinbergDADesign and synthesis of actinium-225 radioimmunopharmaceuticalsAppl Radiat Isot200257684184712406626
   PubMed Web of Science ®Google Scholar
• HilmasDEGilletteELMorphometric analyses of the microvasculature of tumors during growth and after x-irradiationCancer19743311031104810083
   PubMed Web of Science ®Google Scholar
• HaasTLDulingBRMorphology favors an endothelial cell pathway for longitudinal conduction within arteriolesMicrovasc Res19975321131209143542
   PubMed Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis and tissue factorNat Med1996221671688574960
   PubMed Web of Science ®Google Scholar
• FolkmanJAnti-angiogenesis: new concept for therapy of solid tumorsAnn Surg197217534094165077799
   PubMed Web of Science ®Google Scholar
• DenekampJEndothelial cell proliferation as a novel approach to targeting tumor therapyBr J Cancer19824511361397059456
   PubMed Web of Science ®Google Scholar
• DenekampJReview article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyBr J Radiol1993667831811967682469
   PubMed Web of Science ®Google Scholar
• BurrrowsFJThorpePEVascular targeting – a new approach to the therapy of solid tumorsPharmacol Ther19946411551747846113
   PubMed Web of Science ®Google Scholar
• FolkmanJAddressing tumor blood vesselsNat Biotechnol19971565109181567
   PubMed Web of Science ®Google Scholar
• KerbelRSAntiangiogenic therapy: a universal chemosensitization strategy for cancer?Science200631257771171117516728631
   PubMed Web of Science ®Google Scholar
• CaiWChenXMultimodality molecular imaging of tumor angiogenesisJ Nucl Med200849Suppl 2113S128S18523069
   PubMed Web of Science ®Google Scholar
• DobruckiLWde MuinckEDLindnerJRSinusasAJApproaches to multimodality imaging of angiogenesisJ Nucl Med201051Suppl 166S79S20457795
   PubMed Web of Science ®Google Scholar
• LeunigMYuanFMengerMDAngiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID miceCancer Res19925223655365601384965
   PubMed Web of Science ®Google Scholar
• KennelSJMirzadehSVascular targeted radioimmunotherapy with 213Bi-an alpha-particle emitterNucl Med Biol19982532412469620629
   PubMed Web of Science ®Google Scholar
• KennelSJLankfordTKFooteLJDavisIABollRAMirzadehSCombination vascular targeted and tumor targeted radioimmunotherapyCancer Biother Radiopharm199914537137910850322
   PubMed Web of Science ®Google Scholar
• KennelSJChappellLLDadachovaKEvaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumorsCancer Biother Radiopharm200015323524410941530
   PubMed Web of Science ®Google Scholar
• KennelSJMirzadehSEckelmanWCVascular-targeted radioimmunotherapy with the alpha-particle emitter 211AtRadiat Res2002157663364112005541
   PubMed Web of Science ®Google Scholar
• NagengastWBde VriesEGHospersGAIn vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograftJ Nucl Med20074881313131917631557
   PubMed Web of Science ®Google Scholar
• StollmanTHScheerMGLeendersWPSpecific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibodyInt J Cancer2008122102310231418240146
   PubMed Web of Science ®Google Scholar
• NayakTKGarmestaniKBaidooKEMilenicDEBrechbielMWPET imaging of tumor angiogenesis in mice with VEGF-A targeted (86)Y-CHX-A”-DTPA-bevacizumabInt J Cancer2010
   Web of Science ®Google Scholar
• NikulaTKBocchiaMCurcioMJImpact of the high tyrosine fraction in complementarity determining regions: measured and predicted effects of radioiodination on IgG immunoreactivityMol Immunol199532128658727565813
   PubMed Web of Science ®Google Scholar
• NilssonFKosmehlHZardiLNeriDTargeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in miceCancer Res200161271171611212273
   PubMed Web of Science ®Google Scholar
• BaumgartnerWDrenckhahnDPlasmalemmal concentration and affinity of mouse vascular endothelial cadherinEur Biophys J200231753253812451422
   PubMed Web of Science ®Google Scholar